RARE: Total pendapatan perusahaan Ultragenyx Pharmaceutical Inc.

ultragenyx.com - logo grafis emiten RARE

Ultragenyx Pharmaceutical is optimizing its processes by outsourcing clinical trials and drug manufacturing to third-party contractors. High R&D investments and patents create significant barriers to entry for competitors under strict FDA oversight. Innovative treatments for rare pathologies are demonstrating steady growth. The company's product revenue on this chart shows that the current level is around 0.73.

Ultragenyx Corp - Dodolan perusahaan RARE (periode 04.07.2022 - 18.11.2026)

Rincian metrik komprehensif lan analitis Ultragenyx Pharma (RARE)

- rega saiki lan proyeksi nilai saham:
Ringkesan analisis perusahaan:RARE, ultragenyx.com
Produk sing diprodhuksi Ultragenyx Pharmaceutical Inc.

Investors should utilize this indicator to filter out overvalued assets and verify the actual market value of Ultragenyx Pharmaceutical (RARE). Given the outsourcing of production to CMOs to minimize capital expenditures, the company's commercial revenue trend reflects the effectiveness of orphan drug commercialization, where turnover growth confirms an operational peak, while stagnation signals critical risks to business sustainability.

Analisis perusahaan pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|BEAM: Pendapatan lan volume dodolan|Sarepta - Pendapatan dodolan perusahaan|TWST (twistbioscience.com) - Pendapatan lan volume dodolan|Volume dodolan perusahaan TXG (10x Genomics Corp)|Pendapatan lan volume dodolan NTLA|Pendapatan lan volume dodolan Stoke Therapeutics, Inc. (STOK)|Pendapatan perusahaan BioLife BLFS|WVE - Dodolan perusahaan|Maze Therapeutics Corp - Pendapatan lan volume dodolan|Sionna Pharma - Total dodolan perusahaan|Prime Medicine (PRME) - Pendapatan perusahaan|tayshagtx.com (TSHA) - Pendapatan lan volume dodolan|Pendapatan perusahaan uniQure Corp|MGTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RGNX|Pendapatan reged perusahaan Solid Corp|Pendapatan lan volume dodolan OCGN (ocugen.com)|PACB (Pacific Biosciences) - Pendapatan tahunan perusahaan|Benitec Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Pendapatan perusahaan|4D Molecular Therapeutics (FDMT) - Pendapatan lan volume dodolan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan